Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-021390

Chief Financial Officer sold 13,286 shares at $30.00 ($398,580)

  • Chief Financial Officer acquired 13,286 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2022-03-24 Option exercise +13,286 $4.12 $54,738 67,545 D: show line 1 in the form
Catinazzo Thomas Chief Financial Officer 2022-03-24 Sale −13,286 $30.00 $398,580 54,259 D: show line 2 in the form
Open-market sales · 13,286 sh · avg $30.00 · $398,580

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Catinazzo Thomas Chief Financial Officer 2022-03-24 Option exercise · Stock Option (Right to Buy) −13,286 26,257 D: show line 3 in the form
Loading xslF345X03/doc4.xml…